Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Community-based Monitoring of Cholera Antibodies' Seroprevalence, and Home Follow-up of Positive Cases, in the Context of Cholera Vaccination Campaign, Democratic Republic of the Congo

NCT05829772 is registered in ClinicalTrials.gov with Epicentre as lead sponsor.

NCT NCT05829772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05829772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Community-based Monitoring of Cholera Antibodies' Seroprevalence, and Home Follow-up of Positive Cases, in the Context of Cholera Vaccination Campaign, Democratic Republic of the Congo
Lead sponsor
Epicentre
Phase
Observational
Overall status
Completed
Start date
September 20, 2021
Completion date
April 1, 2024
Enrollment
7,000 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cholera